82 FR 40163 - Center for Substance Abuse Prevention; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 82, Issue 163 (August 24, 2017)

[Federal Register Volume 82, Number 163 (Thursday, August 24, 2017)]
[Notices]
[Page 40163]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-17963]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet in person and via web conference on September 
19, 2017, from 9:30am to 5:00pm EDT and September 20, 2017, from 9:30am 
to 2:00pm EDT.
    The Board will meet in open session on September 19, 2017, from 
9:30am to 12:45pm to provide updates on the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs, present a study on the 
degradation of deoxyribose nucleic acid (DNA) in urine and oral fluid 
specimens, results from the opioid implementation performance testing 
(PT) samples, lessons learned from the pilot PT program for oral fluid, 
and the detection of opioid glucuronides in drug user hair. Public 
comments are welcome. If you intend to provide public comments, please 
register and provide a summary of your comments to the contact listed 
below. The Division of Workplace Programs will review public comments 
to ensure that they address the topics scheduled to be discussed during 
the meeting and adhere to the meeting's established time limits for 
public comments.
    The board will meet in closed session on September 19, 2017, from 
2:00pm to 5:00pm EDT and on September 20, 2017, from 9:30am to 2:00pm 
EDT to hear about current confidential practices in the hair testing 
industry and to discuss proposed revisions of the Oral Fluid Mandatory 
Guidelines for Federal Workplace Drug Testing Programs. These portions 
of the meeting are closed to the public as determined by the 
Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and 
(9)(B), and 5 U.S.C. App. 2, Section 10(d).
    To obtain the web conference call-in numbers and access codes, 
registration can be completed online at http://snacregister.samhsa.gov/MeetingList.aspx.
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, http://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab, or by contacting Brian Makela.

Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board
Dates/Time/Type: September 19, 2017, from 9:30am to 12:45pm, EDT: Open, 
September 19, 2017, from 2:00pm to 5:00pm, EDT: Closed, September 20, 
2017, from 9:30am to 2:00pm, EDT: Closed
Place: Parklawn Building, Rooom 5E29, 5600 Fishers Lane, Rockville, 
Maryland 20857
Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers 
Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240-276-2600, 
Fax: 240-276-2610, Email: [email protected].

Brian Makela,
Chemist, Substance Abuse and Mental Health Services Administration.
[FR Doc. 2017-17963 Filed 8-23-17; 8:45 am]
 BILLING CODE 4162-20-P